![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 09, 2020 6:20:59 PM
https://www.nurixtx.com/arthur-t-sands-m-d-ph-d/
Recent NRIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 11:02:24 AM
- Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) • GlobeNewswire Inc. • 06/16/2024 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:39:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 11:30:50 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 06/11/2024 08:06:01 PM
- Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024) • GlobeNewswire Inc. • 06/10/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:01:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:36:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:58:39 PM
- Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer • GlobeNewswire Inc. • 05/28/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 11:06:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 11:25:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 11:25:10 PM
- Nurix Therapeutics Announces Board Chair Transition • GlobeNewswire Inc. • 05/20/2024 08:00:00 PM
- Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of NX-5948, a Selective Bruton’s Tyrosine Kinase (BTK) Degrader, at the European Hematology Association Congress (EHA2024) • GlobeNewswire Inc. • 05/14/2024 02:00:00 PM
- Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 04/16/2024 10:21:52 PM
- Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering • GlobeNewswire Inc. • 04/12/2024 03:38:26 AM
- Nurix Therapeutics Announces Proposed Public Offering • GlobeNewswire Inc. • 04/11/2024 08:00:01 PM
- Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 04/10/2024 11:00:00 AM
- Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies • GlobeNewswire Inc. • 04/09/2024 05:15:00 PM
- Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6 • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- Nurix Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM